Strength of Recommendation Taxonomy (SORT): A Patient-Centered Approach to Grading Evidence in the Medical Literature

References

1. ↵
   Anonymous. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA 1992; 268: 2420–5.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Slawson DC, Shaughnessy AF, Bennett JH. Becoming a medical information master: feeling good about not knowing everything. J Fam Pract 1994; 38: 505–13.

   OpenUrlPubMedWeb of Science
3. Shaughnessy AF, Slawson DC, Bennett JH. Becoming an information master: a guidebook to the medical information jungle. J Fam Pract 1994; 39: 489–99.

   OpenUrlPubMedWeb of Science
4. Siwek J, Gourlay ML, Slawson DC, Shaughnessy AF. How to write an evidence-based clinical review article. Am Fam Physician 2002; 65: 251–8.

   OpenUrlPubMedWeb of Science
5. ↵
   Systems to rate the strength of scientific evidence. Evidence report/technology assessment: number 47. AHRQ publication no. 02-E015. Rockville (MD): Agency for Healthcare Research and Quality; 2002. Available at: URL: .
6. ↵
   Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20(3 Suppl): 21–35.

   OpenUrl
7. ↵
   Clarke M, Oxman AD. Cochrane reviewer’s handbook 4.0. The Cochrane Collaboration; 2003. Available at: URL: http://www.cochrane.org/resources/handbook/.
8. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, et al. An approach to the development of practice guidelines for community health interventions. Can J Public Health 1994; 85(Suppl 1): S8–13.
9. Briss PA, Zaza S, Pappaioanou M, et al. Developing an evidence-based guide to community preventive services—methods. Am J Prev Med 2000; 18(1 Suppl): 35–43.

   OpenUrl
10. Greer N, Mosser G, Logan G, Halaas GW. A practical approach to evidence grading. Jt Comm J Qual Improv 2000; 26: 700–12.

    OpenUrlPubMed
11. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users’ Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the users’ guides to patient care. JAMA 2000; 284: 1290–6.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Anonymous. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967–75.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardia Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781–8.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996; 335: 533–9.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Moseley JB, O’Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347: 81–8.

    OpenUrlCrossRefPubMedWeb of Science
16. Dwyer T, Ponsonby AL. Sudden infant death syndrome: after the “back to sleep” campaign. BMJ 1996; 313: 180–1.

    OpenUrlFREE Full Text
17. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154–60.

    OpenUrlCrossRefPubMedWeb of Science
18. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003; (1): CD001960.
19. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.

    OpenUrlCrossRefPubMedWeb of Science
20. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published erratum appears in Lancet 1999;354:602]. Lancet 1998; 352: 837–53.

    OpenUrlCrossRefPubMedWeb of Science
21. Meunier PJ, Sebert JL, Reginster JY, et al. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int 1998; 8: 4–12.

    OpenUrlCrossRefPubMedWeb of Science
22. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988; 260: 1910–6.

    OpenUrlCrossRefPubMedWeb of Science
23. Grumbach K. How effective is drug treatment of hypercholesterolemia? A guided tour of the major clinical trials for the primary care physician. J Am Board Fam Pract 1991; 4: 437–45.
24. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27–34.
25. ↵
    Centre for Evidence-Based Medicine. Levels of evidence and grades of recommendation. Available at: URL: http://www.cebm.net/levels_of_evidence.asp.
26. ↵
    Family Practice Inquiries Network (FPIN). Available at: URL: http://www.fpin.org.